These studies nonetheless indicate that the combination of IFN-γ and TNF-α are capable of inducing, for many breast cancer lines, reductions in surface expression of HER family proteins in vitro, similar to what is observed in vivo with DC-based vaccinations that induce strong Th1 immunity. Here, IFNG is linked to breast cancer.